Study details
Enrolling now
Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness
NYU Langone Health
NCT IDNCT06698809ClinicalTrials.gov data as of Apr 2026
Target enrollment
18
Study length
about 7 months
Ages
18–75
Locations
1 site in NY
What this study is about
This trial is testing if transcranial photobiomodulation (tPBM) can help reduce residual sleepiness in people with obstructive sleep apnea. tPBM uses red and near-infrared light to potentially change brain activity and blood flow, which may improve sleepiness.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Active tPBM
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.